NDA 214857 · Air Liquide Canada INC
Oxygen, Usp
Oxygen · Inhalation
Last checked: Nov 19, 2026Latest source record: Jun 2, 2020 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
2020
Jun 2, 2020
Approved uses
1
Original approval plus efficacy supplements
Registered trials
2,260
376 Phase 3, 196 recruiting
FAERS reports
0
0 serious, 0 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
No structured label for this application in openFDA. Older and discontinued products often have none.
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
- Jun 2, 2020 Original approval Letter
1 products under this application
- OXYGEN, USP · OXYGEN N/A · GAS, INHALATION · Prescription
Clinical trials
Interventional ClinicalTrials.gov studies with "Oxygen" as an intervention, any sponsor and status, largest first.
- Randomised Evaluation of COVID-19 TherapyPivotal-lookingRecruiting
University of OxfordAcademic, hospital or other
NCT04381936 · 70,000 participants (planned) · Start Mar 19, 2020 · Primary completion Sep 30, 2028
Drug: Lopinavir-Ritonavir; Corticosteroid and 20 more · For: Pneumonia
Sites: Brussels, Belgium; Tallinn, Estonia; Paris, France · 16 sites in all
- Sanitation, Water, and Instruction in Face-washing for Trachoma I/IIPivotal-lookingCompleted
University of California, San FranciscoAcademic, hospital or other
NCT02754583 · 47,605 participants · Start Dec 5, 2015 · Primary completion Dec 31, 2024
Drug: Azithromycin; Tetracycline · For: Trachoma
Sites: Addis Ababa, Ethiopia
- Targeted Active Case Detection Among High Risk Populations in Southern Lao Peoples Democratic RepublicPivotal-lookingCompleted
University of California, San FranciscoAcademic, hospital or other
NCT03783299 · 39,968 participants · Start Nov 28, 2017 · Primary completion Nov 30, 2018
Drug: Artemether-lumefantrine; Primaquine Phosphate · For: Plasmodium Falciparum Malaria
Sites: Vientiane, Laos
- Reducing the Burden of Malaria by Targeting Hotspots of Malaria TransmissionPivotal-lookingCompleted
Radboud University Medical CenterAcademic, hospital or other
NCT01575613 · 17,506 participants · Start Apr 2012 · Primary completion Nov 2012
Drug: Artemether-lumefantrine combination; Bacillus thuringiensis and 2 more · For: Malaria
Sites: Rachuonyo District, Kenya
- A Community Setting Study of Malaria After Systematic Treatment of Symptomatic Carriers of P. Falciparum With COA566 (Coartem®)Pivotal-lookingCompleted
NovartisNovartis (NVS)
NCT01256658 · 14,075 participants · Start Nov 2010 · Primary completion Jul 2012
Drug: COA566 · For: Malaria
Sites: Ouagadougou, Burkina Faso; Burkina Faso, Burkina Faso · 3 sites in all
- Perioperative Respiratory Care and Outcomes for Patients Undergoing High Risk Abdominal SurgeryPivotal-lookingCompleted
University of BirminghamAcademic, hospital or other
NCT04256798 · 11,668 participants · Start Nov 13, 2020 · Primary completion Aug 19, 2026
Drug: Chlorhexidine mouthwash; Oxygen and 1 more · For: Infection; Pneumonia; Surgical Site Infection and 9 more
Sites: Botucatu, Brazil; Porto Alegre, Brazil; Salvador, Brazil · 38 sites in all
- Duration of Cardiac Antimicrobial Prophylaxis Outcomes StudyPivotal-lookingRecruiting
Monash UniversityAcademic, hospital or other
NCT05447559 · 9,180 participants (planned) · Start Feb 7, 2023 · Primary completion Dec 2027
Drug: Cefazolin; Water for injection · For: Surgical Site Infection
Sites: Dallas, Texas; Sydney, Australia; Brisbane, Australia · 27 sites in all
- PeRiOperative Medicine Platform TrialPivotal-lookingRecruiting
Monash UniversityAcademic, hospital or other
NCT07186634 · 7,800 participants (planned) · Start Apr 6, 2026 · Primary completion Dec 2035
Drug: Liberal inspired oxygen; Conservative inspired oxygen and 1 more · For: Surgical Site Infection After Major Surgery; Anaesthesia; Major Complications and 2 more
Sites: Melbourne, Australia; Wellington, New Zealand
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
No FAERS reports name this application.
FAERS reports by year
By the date FDA received the report.
No reports.
Recalls
0 FDA enforcement reports for this application.
No recalls on record for this application.
Shortages
FDA's drug shortage list.
Not on FDA's shortage list.
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- High-flow nasal cannula therapy for infants with bronchiolitis.
Armarego M, Forde H, Wills K, et al. · Cochrane Database Syst Rev 2024 · Meta-Analysis, Systematic Review
- The Relationship Between Running Biomechanics and Running Economy: A Systematic Review and Meta-Analysis of Observational Studies.
Van Hooren B, Jukic I, Cox M, et al. · Sports Med 2024 · Systematic Review, Meta-Analysis
- The Effects of Head Elevation on Intracranial Pressure, Cerebral Perfusion Pressure, and Cerebral Oxygenation Among Patients with Acute Brain Injury: A Systematic Review and Meta-Analysis.
Ramos MB, Britz JPE, Telles JPM, et al. · Neurocrit Care 2024 · Systematic Review, Meta-Analysis
- Effectiveness of preoxygenation strategies: a systematic review and network meta-analysis.
Crístian de Carvalho C, Iliff HA, Santos Neto JM, et al. · Br J Anaesth 2024 · Systematic Review, Network Meta-Analysis
- Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis.
Chu DK, Kim LH, Young PJ, et al. · Lancet 2018 · Comparative Study, Meta-Analysis
- The effects of kangaroo mother care on physiological parameters of premature neonates in neonatal intensive care unit: A systematic review.
Zengin H, Suzan OK, Hur G, et al. · J Pediatr Nurs 2023 · Systematic Review, Meta-Analysis
Sponsor: Air Liquide Canada INC
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.